Büttelborn, Germany

Alfons Enhsen



Average Co-Inventor Count = 4.5

ph-index = 10

Forward Citations = 378(Granted Patents)


Location History:

  • Buettelborn, DE (2000)
  • B{umlaut over (u)}ttelborn, DE (2001)
  • Buttelborn, DE (1995 - 2006)
  • Büttelborn, DE (2001 - 2007)
  • Buettleborn, DE (2010)

Company Filing History:


Years Active: 1995-2010

Loading Chart...
Loading Chart...
23 patents (USPTO):

Title: Innovations in Medicinal Chemistry: The Contributions of Alfons Enhsen

Introduction

Alfons Enhsen, a prolific inventor based in Büttelborn, Germany, has made significant advancements in the field of medicinal chemistry, exemplified by his impressive portfolio of 23 patents. His innovations, particularly in pharmaceutical compounds, highlight his dedication to addressing pressing health issues, such as type II diabetes.

Latest Patents

Among Alfons Enhsen's notable recent patents are the developments of carboxyalkoxy-substituted acyl-carboxyphenylurea derivatives. These inventions relate to acyl-carboxyphenylurea derivatives and their physiologically tolerated salts and functional derivatives, offering potential new avenues for treating type II diabetes. The compounds described in these patents are characterized by specific formulas, demonstrating their suitability as therapeutic agents by enhancing physiological tolerance.

Another significant patent is focused on acyl-4-carboxyphenylurea derivatives, which also include processes for their preparation and use. Similar to his previous work, this invention underscores their application as antidiabetics, thereby reinforcing Enhsen's commitment to combating diabetes through innovative pharmaceutical solutions.

Career Highlights

Throughout his career, Alfons Enhsen has worked with prominent pharmaceutical companies, including Aventis Pharma Deutschland GmbH and Hoechst Aktiengesellschaft. His experience in these reputable organizations has played a crucial role in his development as an innovator in the pharmaceutical industry, allowing him to contribute significantly to research and development in medicinal compounds.

Collaborations

Enhsen has collaborated with esteemed colleagues such as Heiner Glombik and Werner Kramer. These partnerships have further enriched his research endeavors, enabling him to synergize ideas and innovate more effectively in the realm of medicinal chemistry.

Conclusion

In summary, Alfons Enhsen's fruitful career is marked by his valuable contributions to the field of medicinal chemistry, particularly through his groundbreaking patents that hold promise for the treatment of type II diabetes. His collaborative spirit and experience at prestigious companies underscore the importance of teamwork in innovation. As the field of medicine continues to evolve, inventors like Enhsen play a crucial role in advancing health solutions for global communities.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…